Oh Soyoung, Seo Haesook
Infectious Disease Research Center, Citizen's Health Bureau, Seoul Metropolitan Government, 110, Sejong-daero, Jung-gu, Seoul, 04524, Republic of Korea.
Heliyon. 2023 May;9(5):e15668. doi: 10.1016/j.heliyon.2023.e15668. Epub 2023 Apr 21.
Dysbiosis of the gut microbiota with aging contributes to a reduction in important cross-feeding bacterial reactions in the gut and immunosenescence, which could contribute to a decrease in vaccine efficacy. Fever, cough, and fatigue are the main signs of coronavirus disease 2019 (COVID-19); however, some patients with COVID-19 present with gastrointestinal symptoms. COVID-19 vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is one of the best measures to reduce SARS-CoV-2 infection rates and the severity of COVID-19. The immunogenicity of COVID-19 vaccines is influenced by the composition of the gut microbiota, and the immune response to COVID-19 vaccines decreases with age. In this review, we discuss gut microbiota dysbiosis and immunosenescence in the older adults, the role of gut microbiota in improving the efficacy of COVID-19 vaccines, and dietary interventions to improve the efficacy of COVID-19 vaccines in the older adults.
肠道微生物群的失调会随着年龄的增长而导致肠道中重要的交叉喂养细菌反应减少和免疫衰老,这可能会导致疫苗效力下降。发热、咳嗽和疲劳是2019冠状病毒病(COVID-19)的主要症状;然而,一些COVID-19患者会出现胃肠道症状。针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的COVID-19疫苗接种是降低SARS-CoV-2感染率和COVID-19严重程度的最佳措施之一。COVID-19疫苗的免疫原性受肠道微生物群组成的影响,并且对COVID-19疫苗的免疫反应会随着年龄的增长而降低。在这篇综述中,我们讨论了老年人的肠道微生物群失调和免疫衰老、肠道微生物群在提高COVID-19疫苗效力方面的作用,以及改善老年人COVID-19疫苗效力的饮食干预措施。